A possible relationship may exist between the concentration of heparin-activated plasma clearing factor and alterations in lipid metabolism associated with advancing age, atherosclerosis, and other diseases. To test this hypothesis, 121 men were evaluated in the development and application of a standardized in vitro method for the determination of clearing factor response to minimal heparin stimulation. Eighty-four men, ranging from 21 to 93 years, selected from this group, were evaluated in an age-wise study. Patients with diagnoses of recent myocardial infarction (presumptive evidence of coronary atherosclerosis), cirrhosis of the liver, and chronic alcoholism were also tested.
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DURING the past 6 years, many studies of lipid metabolism and its derangements have been concerned with a clearing factor evoked in blood plasma by the in vivo injection of heparin. Since the observation that heparin administration clears the turbidity of alimentary lipemic plasma,' many investigators have sought to elucidate its mechanisms.2-7 Clearing factor has been identified as a plasma lipase, now called "lipoprotein lipase,"8' 9 which hydrolyses the triglyceride of lipoproteins or fat emulsions, reducing it to free fatty acid and glycerol.2 5 A linear relationship has been observed during the initial in vitro clearing of a standard fat emulsion by heparinactivated plasma and the release of free fatty acid.3' 4Furthermore, it has been shown that the rate of in vitro clearing of a fat emulsion is proportional to the concentration of clearing factor present, and that the in vitro clearing activity of postheparin plasma may be quantitatively accounted for on the basis of its lipolytic activity.3' 4 In view of the possible relationship of plasma clearing factor concentration to atherosclerosis and other diseases associated with alterations in lipid metabolism, clearing factor response has been extensively investigated in man.'0- '4 Similarity between possible alterations in lipid metabolism with advancing age and atherosclerosis has been suggested by experiments in From the Gerontology Branch, National Heart Institute, National Institutes of Health, U. S. Public Health Service, Bethesda, and the Baltimore City Hospitals, Baltimore, Md. 889 which standard fat meals were administered to young and old subjects'5 16 and to patients with coronary atherosclerosis.10 11, 13 Both the old subjects and those with atherosclerosis demonstrated prolonged high levels of alimentary chylomicronemia"5 and lipemia."' 16 Heparin injection after a standard fat meal, in: one study, demonstrated a decreased clearing response in patients with coronary atherosclerosis," and in another study, no decrease in clearing response in atherosclerotic subjects" as compared to controls. In a third report,13 heparin was found to accelerate the clearing of alimentary lipemia in normal subjects and to initiate the clearing response in subjects with coronary atherosclerosis after a standard fat meal.
When fasting subjects with coronary atherosclerosis, the nephrotic syndrome, and idiopathic hyperlipemia were evaluated with respect to their clearing factor response,'2 the normal control subjects demonstrated the greatest clearing; the patients with atherosclerosis slightly less; and the nephrotic and idiopathic hyperlipemic subjects considerably less clearing. Another observer'4 found a variable clearing factor response in atherosclerotic patients, normal or elevated clearing in young subjects, and decreased or absent clearing in old subjects or those suffering from precocious senility. Although one study '7 demonstrated significantly lower blood lipase levels in older people than in the young, these same investi-intravenous injection of fatty plasma in old subjects as compared to young subjects.
Inasmuch as no uniform technic or heparin dosage was employed to determine clearing factor response to heparin stimulation in the various studies cited above, results of these investigations cannot be compared with each other. The research reported here was designed to analyze various factors in the development of a standardized in vitro assay method for the evaluation of clearing factor response to minimal heparin stimulation in man and to apply this method to a study of possible age differences in clearing factor response in men. Observations were also made on patients with recent myocardial infarction and cirrhosis of the liver.
MATERIAL AND METHODS
One hundred and twenty-one men were selected from the population of the Infirmary Division (Old Peoples' Home) and from convalescent patients of the Baltimore City Hospitals. These were utilized in the analysis of various factors in the development of a standardized in vitro assay method for the determination of clearing factor response to minimal heparin stimulation. From this group, 84 men, ranging from 21 to 93 years of age, were selected for an evaluation of possible age differences in clearing factor response. All subjects were afebrile, free from evident acute infection, and on ward diet for at least 1 week prior to test. None had evidence of recent myocardial infarction, congestive heart failure, clinical jaundice, uncontrolled diabetes mellitus, the nephrotic syndrome, or had received heparin within 1 week prior to study. No attempt was made to identify subjects with or without atherosclerosis, in view of the improbability of completely excluding this disease in any subject in the age group studied. Tests were also performed on 7 subjects with a diagnosis of recent myocardial infarction and 6 subjects with a diagnosis of cirrhosis of the liver.
Heparin Sodium, 3 mg. in 5 ml. of isotonic saline* injected intravenously, was used as the clearing factor stimulus. Control and 8-minute postheparin blood samples (25 ml.) were obtained from all subjects after an overnight fast (at least 12 hours). Blood samples were immediately mixed with dried sodium oxalate (1 mg./ml. blood) and cooled to 0 C. in an ice bath. The plasma was separated by centrifugation at 0 C. It was subsequently kept at 0 C. or Consequently, all plasma was extracted at 0 C. and kept at 0 C. until used.
Although 25 ml. of blood were used in these studies, several parameters being evaluated on aliquots of the same plasma, the test may be performed with 10 ml. of blood or less, 3.0 ml. of postheparin plasma being required.
In this in vitro test, if the fat emulsion substrate is acted upon by an enzyme system and the optical density at 6500 A is a measure of the concentration of fat emulsion present, the optical density of the mixture would decrease at a constant rate determined by enzyme concentration as long as excess substrate was present. Under these circumstances, this rate could be determined by noting the change in optical density in a given period of time,'0 or the time required for given change in optical density.3 The negative slope of a plot of optical density versus time is not constant, but may increase to a maximum in 0 to 60 minutes, and decrease subsequently, or approach an asymptote. The approximately constant maximal rate of change, usually of the midportion of the curve, has been used and is shown to be well reproducible. This is closer to the maximal rate than the mean rate of change for the period of observation, or the time required for a given change in optical density, and provides a wider spread of values than the use of only 2 points.
It is recognized that clearing factor may act simultaneously upon both an exogenous standard fat emulsion that contributes turbidity and an endogenous nonturbid lipoprotein-linked triglyceride. However, it is suggested that the endogenous lipoprotein-linked triglyceride per se does not exert an appreciable influence upon the initial rate of clearing of fat emulsion. This is postulated in view of the observations4 that there is a constant ratio (1.4:1.0) between per cent change in optical density to per cent of coconut oil total fatty acid released in free form, and that the amount of free fatty acid released during clearing never reached the total amount of coconut oil fatty acid added to the incubation mixture even when clearing was complete and the optical density of the mixture had returned to control levels. Thus, even the exogenous fat emulsion substrate is probably not completely hydrolysed during the initial clearing reaction. Under the standardized conditions of the study discussed here, it is suggested that there is excess albumin to act as a fatty acid acceptor, even in cases of hypoalbuminemia. This is postulated in view of the fact that in cirrhotic patients with severe parenchymal liver damage, hypoalbuminemia, and marked inversion of the albumin:globulin ratio, rapid clearing progresses as a linear rate of change of optical density with time. Furthermore, even assuming a hypoalbuminemia of 2 Gm. per 100 ml. of plasma in the in vitro system used in these studies, the exogenous fat emulsion substrate is of the order of 3 mg., while the amount of albumin available as fatty acid acceptor is of the order of 90 mg. In other circumstances, where the hypoalbuminemia is accompanied by marked endogenous hyperlipemia, it is conceivable that conditions for an in vitro clearing reaction may not be optimal. This may be the result of either an initially high optical density of the plasma due to visible endogenous lipemia or to lack of sufficient free fatty acid acceptor or both. In such cases, appropriate modification of the in vitro clearing system might be considered.
No evidence was obtained in this study to in-dicate a decrease in intravascular clearing factor response, either in old subjects or in patients with recent myocardial infarction. Consequently, it would appear unlikely that the persistent lipemial" 16 and chylomicronemia," which have been reported for old subjects'5, 16 and patients with coronary atherosclerosis'3 after a standard fat meal, are due to an intravascular deficiency or absence of clearing factor or its precursors. Clearing factor response can be evoked by minimal intravenous exogenous heparin stimulation in these subjects to at least the same degree as that found in young subjects or subjects without recent myocardial infarction. Evidence indirectly implicating the gastrointestinal tract is found in the equal response of old and young subjects with respect to disappearance rate of chylomicrons following intravenous injection of fatty plasma'5 and the 21 per cent decrease in pancreatic lipase in old versus young men.'8 Further information suggesting gastrointestinal involvement is supplied by the observation that intravenous infusion of a fat emulsion evokes a decrease in serum lipids and changes in their electrophoretic pattern in normal human subjects during alimentary lipemia, in patients with idiopathic hyperlipemia, and in dogs.'9 These alterations appear to be identical with those produced in serum lipids by intravenous heparin injection. Thus, while intravenously administered fatty plasma or fat emulsions may produce adequate clearing and hydrolysis of triglyceride, endogenous production of clearing factor in response to the stimulus of a fatty meal via the gastrointestinal tract may be impaired in old subjects, in patients with coronary atherosclerosis, and perhaps also in patients with idiopathic hyperlipemia.
The increased k obtained in 10 patients with diagnoses of chronic alcoholism or cirrhosis of the liver supports another report14 of a greatly increased clearing factor response in a subject with ethanolic cirrhosis of the liver. Perfusion experiments in rats,20 wherein citrated plasma was mixed with heparin and perfused through the isolated hind limbs, the lungs, and all of the abdominal viscera drained by the portal vein, demonstrated clearing factor production in each instance. The liver, however, produced no clearing factor upon such perfusion. Furthermore, perfusion of postheparin plasma (containing active clearing factor) through the liver resulted in a decrease in its clearing activity. Also, in rats injected with heparin, blood from the inferior vena cava, portal vein, and aorta had similar clearing activity, while that from the hepatic vein demonstrated less clearing activity than that of the aortic blood. It is, therefore, suggested that one cause of the increase in clearing factor activity found in the postheparin plasma of some subjects may be a decrease in the functional capacity of the liver parenchymal cells to remove or inactivate clearing factor.
Although no common diagnosis or pathologic etiology could be discovered for the 5 subjects in the sample of 84 Clearing factor response to minimal heparin stimulation was determined in an agewise study of 84 men, ranging from 21 to 93 years. No statistically significant agewise regression was found, although a tendency toward an increase in clearing factor response with age was present.
Four young subjects diagnosed as chronic alcoholics had a mean high k, 3 of these having the highest k's in the 21-59 age group. Six additional patients with cirrhosis of the liver also had a mean high k value. Liver pathology, either subclinical or clinical, may account for these high k values.
Seven patients with recent myocardial infarction (presumptive evidence of coronary atherosclerosis) demonstrated no lesser clearing factor response to intravenous heparin stimulation than did subjects who were not known to have had a recent myocardial infarction. 
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